Public filings / TEVA on Yahoo Finance (opens in a new tab)
TEVA: insider buying, 13F holders, analyst moves
Teva Pharmaceutical Industries Ltd - US ADR
A summary of public filings about Teva Pharmaceutical Industries Ltd - US ADR. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold TEVA
Combined reported value $739.0M; 1 sold out since Q1 2026.
Holders among our 100 managers: 7 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Rubric Capital | $527.7M | 4.84% | Added |
| Glenview Capital | $172.1M | 3.44% | Trimmed |
| Duquesne Family Office | $21.2M | 0.49% | Trimmed |
| Tudor Investment | $16.6M | 0.07% | Trimmed |
| Farallon Capital | $1.4M | 0.01% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.